Hikari Power’s Nektar Therapeutics NKTR Stock Holding History

Hikari Power’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-393	Closed	-$210K	–	121
2019 Q2	$210K	Buy	+393	New	+$197K	0.02%	97

Other funds holding NKTR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hikari Power's NKTR Position: Q3 2019 in Review

Hikari Power sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 393 shares — an estimated $210K sold.

Hikari Power first reported a position in NKTR in Q2 2019 and held it in 1 quarter. The position peaked at $210K in Q2 2019. 288 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

Hikari Power reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
Hikari Power sold 393 Nektar Therapeutics shares in Q3 2019, an estimated $210K.
Hikari Power first reported a position in Nektar Therapeutics in Q2 2019 and held it in 1 quarter.
Hikari Power's Nektar Therapeutics position peaked at $210K in Q2 2019.
288 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on Hikari Power's 13F filing for Q3 2019, filed 31 Oct 2019.